 | Up a level |
CRASH-3 trial collaborators,
(2019)
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
Lancet (London, England), 394 (10210).
pp. 1713-1723.
Brenner, Amy 
ORCID: 0000-0003-2017-5994, Belli, Antonio, Chaudhri, Rizwana, Coats, Timothy, Frimley, Lauren, Jamaluddin, Sabariah Faizah, Jooma, Rashid, Mansukhani, Raoul, Sandercock, Peter, Shakur-Still, Haleema et al (show 3 more authors)
(2020)
Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
Critical care (London, England), 24 (1).
560-.